Biotest
BIO.F
$61.95
Share price
0.48%
Change (1 day)
2.92%
Change (1 year)
Categories
Revenue for Biotest (BIO.F)
Revenue in 2024 (TTM): S$1.02 Billion
According to Biotest
's latest financial reports the company's current revenue (TTM 
) is S$1.03 Billion. In 2023 the company made a revenue of S$0.97 Billion an increase over the revenue in the year 2022 that were of S$0.73 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Biotest from 2009 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | S$1.02 B | 4.8% |
| 2023 | S$0.97 B | 33.99% |
| 2022 | S$0.73 B | -9.87% |
| 2021 | S$0.81 B | 8.91% |
| 2020 | S$0.74 B | 17.67% |
| 2019 | S$0.63 B | -1.56% |
| 2018 | S$0.64 B | 60.6% |
| 2017 | S$0.40 B | -51.23% |
| 2016 | S$0.82 B | -10.96% |
| 2015 | S$0.92 B | -7.73% |
| 2014 | S$0.99 B | 18.38% |
| 2013 | S$0.84 B | 20.44% |
| 2012 | S$0.70 B | -7.04% |
| 2011 | S$0.75 B | 18.17% |
| 2010 | S$0.63 B | -26.65% |
| 2009 | S$0.86 B |